[1]
N. Shrivastava and R. Rani, “Efficacy and safety of ormeloxifene, a selective estrogen receptor modulator in management of dysfunctional uterine bleeding in perimenopausal patients: a prospective interventional study”, Int J Reprod Contracept Obstet Gynecol, vol. 12, no. 12, pp. 3474–3478, Nov. 2023.